Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.30 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2709796 | 0.95 | MEN1 (0.35) | MEN1KMT2A | |
| SCHEMBL2728669 | 0.91 | MEN1 (0.33) | MEN1KMT2AALDH1A1KDM4EGAA | |
| SCHEMBL2710306 | 0.90 | MEN1 (0.42) | MEN1KMT2AALDH1A1NPSR1KDM4E | |
| SCHEMBL2724744 | 0.90 | MEN1 (0.35) | MEN1KMT2AALDH1A1NPSR1NPC1 | |
| SCHEMBL2725695 | 0.90 | MEN1 (0.38) | MEN1KMT2A | |
| SCHEMBL2709631 | 0.89 | MEN1 (0.35) | MEN1KMT2AALDH1A1 | |
| SCHEMBL2712747 | 0.89 | MEN1 (0.38) | MEN1KMT2AALDH1A1NPSR1NPC1 | |
| SCHEMBL2712156 | 0.88 | MEN1 (0.41) | MEN1KMT2AALDH1A1NPSR1KDM4E | |
| SCHEMBL2712821 | 0.88 | MEN1 (0.35) | MEN1KMT2A | |
| SCHEMBL2712696 | 0.87 | MEN1 (0.37) | MEN1KMT2AALDH1A1NPSR1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2445987-B1 | BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS | CYALUME TECH INC (US) | 2018-05-02 | — | — | EP | disclosed |
| US-8257620-B2 | Blue/violet diphenylanthracene chemiluminescent fluorescers | CYALUME TECHNOLOGIES, INC. (US) | 2012-09-04 | — | — | US | disclosed |
| US-8257620-B2 | Blue/violet diphenylanthracene chemiluminescent fluorescers | CYALUME TECHNOLOGIES, INC. (US) | 2012-09-04 | — | — | US | disclosed |
| CN-102482573-A | Blue/violet diphenylanthracene chemiluminescent fluorescers | CYALUME TECHNOLOGIES INC | 2012-05-30 | — | — | CN | disclosed |
| US-20100327240-A1 | Blue/violet diphenylanthracene chemiluminescent fluorescers | CYALUME TECHNOLOGIES, INC. | 2010-12-30 | — | — | US | disclosed |
| US-20100327240-A1 | Blue/violet diphenylanthracene chemiluminescent fluorescers | CYALUME TECHNOLOGIES, INC. | 2010-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100327240-A1 | Blue/violet diphenylanthracene chemiluminescent fluorescers | CYP2F1, FLAD1, AFF1 | MEN1 1898/4885KMT2A 3905/4885ALDH1A1 34/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.